R&D Department, SILAB, Brive la Gaillarde, France.
MéDIAN UMR CNRS 7369, University of Reims Champagne-Ardenne, Reims, France.
Exp Dermatol. 2018 Apr;27(4):403-408. doi: 10.1111/exd.13388. Epub 2017 Aug 30.
Atopic dermatitis (AD) is the most common skin inflammatory disease, affecting up to 3% of adults and 20% of children. Skin barrier impairment is thought to be the primary factor in this disease. Currently, there is no method proposed to monitor non-invasively the different molecular disorders involved in the upper layer of AD skin. Raman microspectroscopy has proved to be a powerful tool to characterize some AD molecular descriptors such as lipid content, global hydration level, filaggrin and its derivatives. Our investigations aimed to extend the use of in vivo Raman microspectroscopy as a rapid and non-invasive diagnostic technique for lipid conformation and organization, protein secondary structure and bound water content analysis in atopic skin. Our approach was based on the analysis of Raman data collected on the stratum corneum (SC) of 11 healthy and 10 mild-to-moderate atopic patients. Atopic skin revealed a modification of lipid organization and conformation in addition to the decrease of the lipid-to-protein ratio. This study also highlighted a reduction of the bound water and an increase in protein organized secondary structure in atopic skin. All these descriptors worsen the barrier function, state and appearance of the skin in AD. This precise and relevant information will allow an in vivo follow-up of the pathology and a better evaluation of the pharmacological activity of therapeutic molecules for the treatment of AD.
特应性皮炎(AD)是最常见的皮肤炎症性疾病,影响多达 3%的成年人和 20%的儿童。皮肤屏障损伤被认为是这种疾病的主要因素。目前,还没有提出非侵入性监测 AD 皮肤上层涉及的不同分子紊乱的方法。拉曼微光谱已被证明是一种强大的工具,可用于表征 AD 的一些分子描述符,如脂质含量、整体水合水平、丝聚蛋白及其衍生物。我们的研究旨在扩展体内拉曼微光谱的应用,作为一种快速、非侵入性的诊断技术,用于分析特应性皮炎皮肤中的脂质构象和组织、蛋白质二级结构和结合水含量。我们的方法基于对 11 名健康和 10 名轻度至中度特应性皮炎患者的角质层(SC)采集的拉曼数据进行分析。特应性皮炎皮肤的脂质组织和构象发生了改变,脂质与蛋白质的比例降低。这项研究还强调了特应性皮炎皮肤中结合水的减少和蛋白质有序二级结构的增加。所有这些描述符都会使 AD 皮肤的屏障功能、状态和外观恶化。这些精确和相关的信息将允许对病理学进行体内随访,并更好地评估治疗 AD 的治疗分子的药理学活性。